Fig. 2From: The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective studyKaplan-Meier curves for progression-free survival (PFS) (a) and overall survival (OS) (b) of mRCC patients receiving nivolumab as a sequential therapyBack to article page